Kanchem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-12-2024
- Paid Up Capital ₹ 1.00 M
as on 24-12-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -9.93%
(FY 2022)
- Profit -23.99%
(FY 2022)
- Ebitda 264.91%
(FY 2022)
- Net Worth 12.39%
(FY 2022)
- Total Assets 20.86%
(FY 2022)
About Kanchem Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Dugar, Pavan Dugar, and Anil Joshi serve as directors at the Company.
- CIN/LLPIN
U24304GJ2019PTC108107
- Company No.
108107
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kanchem Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Dugar  | Director | 10-May-2019 | Current |
| Pavan Dugar | Director | 10-May-2019 | Current |
| Anil Joshi | Director | 10-May-2019 | Current |
Financial Performance of Kanchem Pharmaceuticals.
Kanchem Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.93% decrease. The company also saw a substantial fall in profitability, with a 23.99% decrease in profit. The company's net worth Soared by an impressive increase of 12.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanchem Pharmaceuticals?
In 2021, Kanchem Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kanchem Pharmaceuticals?
Kanchem Pharmaceuticals has a workforce of 54 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanchem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanchem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
